Comparison of Two Early Treatments for Premature Babies and Their Effects Over Time
PREMOTSENS
Comparison of the Impact of Two Early Interventions on the Development of Premature Infants: a Clinical Study of Short- and Long-term Effects
1 other identifier
interventional
90
1 country
2
Brief Summary
According to the latest World Health Organization report, prematurity is a major health issue, recognized as a significant vulnerability factor contributing to the emergence of neurodevelopmental disorders. Of the various approaches adopted to limit its consequences, the control of the sensory environment and sensory-focused care are relatively recent. Although a number of sensory care approaches exist, few of them address the different sensory modalities jointly and have been scientifically validated. This research project aims to conduct a study in France on the effectiveness of multisensory ATVV (Auditory, Tactile, Visual, and Vestibular stimulation) treatment using a combination of short- and long-term clinical assessments. The research hypothesis is that ATVV care provided before term age will have a greater impact than "Parental Singing" care on the motor parameters and alertness level of premature infants. Given the importance of motor activity on child development, it is hypothesized here that from term age onwards, the development of children in the ATVV group will be less atypical, or even equivalent to that of the group of full-term infants for most of the parameters evaluated. Furthermore, this normalization of the developmental trajectory will be less pronounced for the "Parental Singing" group. However, the sessions for both treatments (Parental Singing and ATVV) should improve early interactions, sucking, and physiological parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
December 3, 2025
December 1, 2025
1.8 years
November 19, 2025
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis of the long-term impact of ATVV care on premature infants
The primary objective is to analyze the long-term impact of ATVV care on premature infants. Motor and cognitive development at 6 months will be compared between premature infants (30 to 34 weeks gestation) receiving ATVV care with premature infants receiving "Singing" care and full-term infants (\>37 weeks gestation), using the Bayley Scales of Infant and Toddler Development, 4th Edition (from 16 days to 42 months) and its motor subscore (assessing fine and gross motor skills) and cognition subscore. A subscore (standardized score) ≥ 85 out of 160 in each domain corresponds to typical development.
The primary endpoint will be measured at 6 months corrected age in premature infants, and at 6 months in full-term infants.
Secondary Outcomes (10)
Motor skills
The outcome is measured between 34 weeks gestational age and 2 months of corrected age.
Overall and communication development
The outcome is measured between 34 weeks gestational age and 2 months of corrected age.
Multisensory integration
The outcome is measured between 34 weeks gestational age and 2 months of corrected age.
Level of alertness
The outcome is measured between 34 weeks gestational age and 2 months of corrected age.
Precocious interactions
The outcome is measured between 34 weeks gestational age and 2 months of corrected age.
- +5 more secondary outcomes
Study Arms (3)
ATVV group
EXPERIMENTALThe experimental group comprising premature infants receiving ATVV care
Parental Singing group
OTHERThe intervention control group comprising premature infants receiving Parental Singing care
Control group
NO INTERVENTIONThe control group comprising full-term infants
Interventions
ATVV consists in providing the infant with multisensory stimulation through massage, talking, eye contact, and gentle rocking.
The singing intervention consists in parents singing softly next to the child's ear.
Eligibility Criteria
You may qualify if:
- For premature infants: birth between 30 and 34 weeks of gestation plus 6 days, and weighing more than 1800 g at the start of the trial.
- For full-term infants: pregnancy and birth without complications at or after 37 weeks of gestation, with an Apgar score ≥7 at 10 minutes after birth.
- For parents or legal guardians:
- Parents over the age of 18
- Parent agreeing to be filmed with their infant (parent who will be responsible for the treatment)
- Parents capable of understanding the information document
- Parent affiliated with or beneficiary of the French social security system
You may not qualify if:
- For premature infants:
- Birth before 30 weeks of gestation
- Weight less than 1800 g at the start of the trial
- Morbidities related to prematurity (necrotizing enterocolitis, cerebral parenchymal damage, stage III and IV intraventricular hemorrhages)
- Presence of a congenital malformation or chromosomal abnormality
- Known sensory, motor, or central nervous system impairment
- Patient receiving non-invasive ventilation at 34 weeks gestational age (CPAP and high-flow nasal cannula)
- For full-term infants:
- Birth before 37 weeks gestation
- Birth with complications
- For the parent providing the treatment and the infant:
- Presence of a known sensory, motor, or central nervous system impairment
- Presence of a congenital condition
- Presence of psychological distress in the parent
- For both parents:
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elsanlead
- Clinique Bouchardcollaborator
Study Sites (2)
Clinique Bouchard
Marseille, France
Hopital Saint-Joseph
Marseille, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 3, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
December 3, 2025
Record last verified: 2025-12